Difference between revisions of "Nucleophosmin"
(New page: {| class="toccolours" border="1" style="float: left; clear: right; margin: 0 0 1em 1em; border-collapse: collapse;" ! {{infobox header}}| '''{{PAGENAME}}''' |- | Substrate peptide name | ...) |
m |
||
| Line 1: | Line 1: | ||
{| class="toccolours" border="1" style="float: left; clear: right; margin: 0 0 1em 1em; border-collapse: collapse;" | {| class="toccolours" border="1" style="float: left; clear: right; margin: 0 0 1em 1em; border-collapse: collapse;" | ||
| − | ! | + | ! {infobox header}| '''{{PAGENAME}}''' |
|- | |- | ||
| Substrate peptide name | | Substrate peptide name | ||
| Line 46: | Line 46: | ||
the central region of the protein is substrate for TG2 | the central region of the protein is substrate for TG2 | ||
|- | |- | ||
| − | | | + | | {infobox header} | |
|- | |- | ||
|} | |} | ||
[[Category:Tissue transglutaminase|*]] | [[Category:Tissue transglutaminase|*]] | ||
Latest revision as of 11:49, 10 March 2015
| Nucleophosmin | |
|---|---|
| Substrate peptide name | Nucleophosmin |
| Synonyms | - |
| Determination type | In situ |
| Source | Homo sapiens |
| Subcellular localization | Nuclear |
| Swissprot ID | P06748 |
| Reactive glutamines | Not determined yet |
| Reactive lysines | Not determined yet |
| Substrate sequence | |
| Structure | 2P1B |
| Surface accessibility | |
| Disorder prediction | IUPred |
| Reference | PMID:18851895 |
| Notes | depleted upon crosslinking by TG2 resulting in anti-apoptotic effects
the central region of the protein is substrate for TG2 |
